Company Profile
Oragenics Stock Price, News & Analysis
- Ticker:
- OGEN
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.54 USD (+0.66%)
Close
Last updated: August 6, 2026
2.75M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, OGEN closed up 0.66% at $0.5435. No new same-company headline was identified in the current news window.
Company overview
Business overview
Oragenics is a biotechnology company focused on infectious disease and central nervous system programs. Its story has long been about using small-cap biotech tools to pursue high-unmet-need therapeutic areas.
Geographic Base and Sector Classification
Oragenics is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
Business Model Characteristics
The company depends on early-stage scientific validation, capital discipline, and the ability to focus its pipeline. Investors watch platform shifts, early data, and financing runway.
Position Within the Biotechnology Landscape
Oragenics occupies a speculative small-cap biotech niche. The stock is driven by whether the company can sharpen its thesis enough to sustain investor confidence.
Future catalysts
Oragenics is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live biotech milestone. The market is focused on residual value.
Recent news
- 01
- 02
- 03
ORAGENICS PROVIDES INVESTOR UPDATE
Source: Oragenics
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Oragenics (OGEN)?
Oragenics (OGEN) most recently closed at 0.54 USD, a +0.66% move versus the previous session.
What is the market cap of Oragenics (OGEN)?
Oragenics currently has a market capitalization of 2.75M USD on BioPharmSignal.
What does Oragenics do?
Oragenics is a biotechnology company focused on infectious disease and central nervous system programs. Its story has long been about using small-cap biotech tools to pursue high-unmet-need therapeutic areas.
On which exchange is OGEN stock listed?
Oragenics (OGEN) is associated with AMEX, United States, Biopharma.
What is Oragenics?
Oragenics is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live biotech milestone.
Which conditions is Oragenics targeting with Oragenics?
Oragenics is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live biotech milestone.
How does Oragenics describe recent progress with Oragenics?
Oragenics is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live biotech milestone.
What future catalysts are investors watching for Oragenics?
Oragenics is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live biotech milestone. The market is focused on residual value.